Identification of new urinary metabolites of byakangelicin, a component of Angelicae dahuricae Radix, in rats

Archives of Pharmacal Research

Volumn 26, Issue 8, 2003, Pages 606-611

  Kwon, Oh Seung ^a   Song, Yun Seon ^a   Shin, Kuk Hyun ^b   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Angelicae dahuricae; Byakangelicin; Metabolism; O Dealkylation; O Demethylation; Rat; Urinary metabolites

Indexed keywords

ANGELICA; ANIMAL; ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANGELICA; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2342521506     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02976709     Document Type: Article

References (13)

1. Ao, S., Kikuchi, C., Ono, T., and Notsu, Y., Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract. Invest. Ophthalmol. Vis. Sci., 32 (12), 3078-3083 (1991).
2. Beyer-Mears, A., Mistry, K., Diecke, F. P., and Cruze, E., Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus. Pharmacology, 52 (5), 292-302 (1996).
3. Beyer-Mears, A. and Cruz, E., Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes, 34 (1), 15-21 (1985).
4. Kador, P. F., The role of aldose reductase in the development of diabetic complications. Med. Res. Rev., 8, 325-352 (1988).
5. Kim, Y. B., Oh, Y. H., Park, I. Y., and Shin, K. H., Crystal structure of byakangelicin. Arch. Pharm. Res., 25 (3), 275-279 (2002).
6. Kimura, Y., Ohminami, H., Arichi, H., Okuda, H., Baba, K., Kozawa, M., and Arichi, S., Effects of various coumarins from roots of Angelica dahurica on actions of adrenalin, ACTH and insulin in fat cells. Planta Med., 45, 183-187 (1982).
7. Oh, H, Lee, H. S., Kim, T., Chai, K. Y., Chung, H. T., Kwon, T. O., Jun, J. Y., Jeong, O. S., Kim, Y. C., and Yun, Y. G., Furonocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med., 68(5), 463-464 (2002).
8. Saiki, Y., Morinaga, K., Okegawa, O., Sakai, S., and Amaya, Y., On the coumarins of the roots of Angelica dahurica Benth et Hook. Yakugaku Zasshi., 91(12), 1313-1317 (1971).
9. Shin, K. H., Chung, M. S., and Cho, T. S., Effects of furanocoumarins from Angelica dahurica on aldose reductase and galactosemic cataract formation in rats. Arch. Pharm. Res., 17(5), 331-336 (1994).
10. Shin, K. H., Kang, S. S., and Chi, H. J., Determination of byakangelicin in Angelicae Radix by high-performance liquid chromatography. Kor. J. Pharmacog., 3, 239-241 (1990).
11. Shin, K. H. and Woo, W. S., Inhibition of hepatic microsomal drug-metabolizing enzyme by imperatorin. Arch. Pharm. Res., 9, 81-85 (1986).
12. Terashima, H., Hama, K., Yamamoto, R., Tsuboshima, M., Kikkawa, R., Hatanaka, I., and Shigeta, Y., Effects of a new aldose reductase inhibitor on various tissues in vitro. J. Pharmacol. Exp. Ther., 229, 226-230 (1984).
13. Tomlinson, D. R., Stevens, E. J., and Diemel, L. T., Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol. Sci., 15, 293-297 (1994).